Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes 08/30/2023 INTERVENTIONAL unchanged 1,092.85 0 Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer 08/30/2023 INTERVENTIONAL unchanged 1,092.85 0 Analysis of Varus Collapse in Obese Patients With Stem and Non-Stem Tibial Components Following Primary Total Knee Arthroplasty 08/31/2023 INTERVENTIONAL unchanged 1,091.85 0 Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer 08/31/2023 OBSERVATIONAL unchanged 1,091.85 0 Hydroxychloroquine May be Beneficial for Preeclampsia 08/31/2023 OBSERVATIONAL unchanged 1,091.85 0 Molecular Markes of Fibrosis of Endometriosis and Their Use in Predicting Disease Severity 08/31/2023 OBSERVATIONAL unchanged 1,091.85 0 Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7 09/01/2023 INTERVENTIONAL unchanged 1,090.85 0 Pessary Experience Study 09/01/2023 OBSERVATIONAL unchanged 1,090.85 0 Characterization of the Pudendal Nerve with Transvaginal Ultrasonography 09/01/2023 OBSERVATIONAL unchanged 1,090.85 0 Prenatal Sonographic Prediction of Placental Histology and Function 09/01/2023 OBSERVATIONAL unchanged 1,090.85 0 Sex Hormones, Postoperative Pain and Opioid Use 09/05/2023 OBSERVATIONAL unchanged 1,086.85 0 A Study of Blood Pressure Control During Cancer Treatment 09/05/2023 INTERVENTIONAL unchanged 1,086.85 0 Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF 09/05/2023 INTERVENTIONAL unchanged 1,086.85 0 A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) 09/05/2023 INTERVENTIONAL unchanged 1,086.85 0 Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy 09/06/2023 OBSERVATIONAL unchanged 1,085.85 0 Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled Trial 09/06/2023 INTERVENTIONAL unchanged 1,085.85 0 Postpartum Hemorrhage Reduction With Oral Tranexamic Acid: a Clinical Trial 09/06/2023 INTERVENTIONAL unchanged 1,085.85 0 Conservative Treatment or Resuturing Among Women With Perineal Wound Dehiscence After Vaginal Labour 09/07/2023 OBSERVATIONAL unchanged 1,084.85 0 Lipidomic Characterization in Non-metastatic Breast Cancer Women Undergoing Surgery: a Pilot Study. 09/07/2023 INTERVENTIONAL unchanged 1,084.85 0 Young Patients With Early Breast Cancer 09/07/2023 OBSERVATIONAL unchanged 1,084.85 0 Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer 09/07/2023 INTERVENTIONAL unchanged 1,084.85 0 Melodi Matrix™ in Breast Reconstruction 09/07/2023 INTERVENTIONAL unchanged 1,084.85 0 PRP Injections for Genitourinary Syndrome of Menopause 09/07/2023 INTERVENTIONAL unchanged 1,084.85 0 Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors 09/07/2023 INTERVENTIONAL unchanged 1,084.85 0 International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study 09/08/2023 OBSERVATIONAL unchanged 1,083.85 0 Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6 09/08/2023 INTERVENTIONAL unchanged 1,083.85 0 A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients 09/08/2023 INTERVENTIONAL unchanged 1,083.85 0 Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I) 09/08/2023 OBSERVATIONAL unchanged 1,083.85 0 The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry 09/08/2023 OBSERVATIONAL unchanged 1,083.85 0 Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women 09/11/2023 INTERVENTIONAL unchanged 1,080.85 0 Artificial Intelligence in Mammography Screening in Norway 09/13/2023 INTERVENTIONAL unchanged 1,078.85 0 Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus 09/13/2023 INTERVENTIONAL unchanged 1,078.85 0 PRO for Fighting FT in Ovarian Cancer 09/13/2023 OBSERVATIONAL unchanged 1,078.85 0 Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion 09/13/2023 INTERVENTIONAL unchanged 1,078.85 0 PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia 09/13/2023 INTERVENTIONAL unchanged 1,078.85 0 Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer 09/13/2023 OBSERVATIONAL unchanged 1,078.85 0 Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer 09/13/2023 INTERVENTIONAL unchanged 1,078.85 0 LATe Cerclage in High-risk Pregnancies (LATCH) 09/14/2023 INTERVENTIONAL unchanged 1,077.85 0 ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial 09/14/2023 INTERVENTIONAL unchanged 1,077.85 0 Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma 09/15/2023 OBSERVATIONAL unchanged 1,076.85 0 Perioperative Immunonutrition Under Enhanced Recovery After Surgery 09/15/2023 INTERVENTIONAL unchanged 1,076.85 0 Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer 09/18/2023 INTERVENTIONAL unchanged 1,073.85 0 A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years 09/18/2023 INTERVENTIONAL unchanged 1,073.85 0 Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism 09/18/2023 INTERVENTIONAL unchanged 1,073.85 0 Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair 09/18/2023 INTERVENTIONAL unchanged 1,073.85 0 AM vs PM Exercise Training 09/18/2023 INTERVENTIONAL unchanged 1,073.85 0 Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs 09/18/2023 INTERVENTIONAL unchanged 1,073.85 0 UmbrelLACT Study: Clinical Lactation Study on the Exposure to Medicines Via Human Milk 09/21/2023 OBSERVATIONAL unchanged 1,070.85 0 A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer 09/21/2023 INTERVENTIONAL unchanged 1,070.85 0 Discovering New Insights Into Anorexia Nervosa: Influence of MicrObial DysbiosiS (DIAMOnDS) 09/21/2023 INTERVENTIONAL unchanged 1,070.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology